Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01316484 · ClinicalTrials.gov registry record
Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms
A clinical trial, sponsored by Tranzyme.
- Completed
- Registry status
- 40
- Enrollment target
NCT01316484 is a clinical trial that has completed, run by Tranzyme. The registered enrollment target is 40 participants.
The verdict
NCT01316484 has completed, sponsored by Tranzyme.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The primary objective of the study is to evaluate how patients with gastroparesis interpret the instructions, item content, and response options of a daily diary questionnaire designed to assess the key symptoms of gastroparesis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01316484
The ClinicalTrials.gov registry entry for NCT01316484 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tranzyme, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01316484 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01316484 about?
NCT01316484 is a clinical study titled "Patient Understanding (Cognitive Debriefing) of a Daily Diary of Gastroparesis Symptoms". The primary objective of the study is to evaluate how patients with gastroparesis interpret the instructions, item content, and response options of a daily diary questionnaire designed to assess the key symptoms of gastroparesis.
What is the current status of trial NCT01316484?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2011-03. Estimated completion is 2011-04.
Who is sponsoring clinical trial NCT01316484?
This trial is sponsored by Tranzyme, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.